"Protez Pharmaceuticals is an outstanding example of the importance of access to funding from Commonwealth-supported organizations such as BioAdvance, which has been a driving force in our growth and success. Protez received seed-stage funding from BioAdvance, and early-stage funding from BioAdvance Ventures. These early-stage investments were critical in our ability to reach company milestones, attract and hire personnel, and attract more than $20 million to date in additional capital to the region. "
Christopher Cashman
Former President and CEO
Protez Pharmaceuticals
Malvern, PA
Christopher Cashman
Former President and CEO
Protez Pharmaceuticals
Malvern, PA
Newsroom
Welcome to the BioAdvance Newsroom, your source for media contact information, BioAdvance and portfolio company press releases and related articles, regional news feeds, and current and back copies of our newsletter, “BioAdvance News.”
Media Contact:
Jennifer Smith
Director of Administration
610-230-0645 or jsmith@bioadvance.com
© Copyright 2008. BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania. All Rights Reserved.